Jehovah’s Witness Patient Undergoing Major Surgery: Methods to Minimize Blood Loss
Abstract
Jehovah's Witnesses are a group of people who refuses to get blood transfusions and blood products due to their faith. Due to this, Jehovah's Witness patients who are planned for major surgical procedures are always a challenge for both surgeons and anaesthetist. Surgical and anaesthetic techniques must be aimed at minimising blood loss. We are reporting a peri-operative management for a Jehovah's Witness patient scheduled for a major surgery. This article emphasizes the techniques to minimize blood lose, in order to avoid blood transfusion.
References
Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion, 2002; 42:812-8.
Reasoning from the Scriptures, Watch Tower Bible & Tract Society, 1989, pages 70–75.
The Royal College of Surgeons of England, Code of practice for the surgical management of Jehovah’s Witnesses, ed. RCSENG-Council, London, 2002.
The association of Anaesthetists of Great Britain and Ireland, Management of Anaesthesia for Jehovah’s Witnesses, London, 1999.
Gyamfi C, Yasin SY. Preparation for an elective surgical procedure in a Jehovah’s Witness: a review of the treatments and alternatives for anemia. Prim Care Update Ob Gyns, 2000, 7:266-268.
Tanaka, A., et al. "Cardiovascular surgery in Jehovah's Witness patients: The role of preoperative optimization." J Thorac Cardiovasc Surg, 2015,150(4): 976-983
Suess S1, Suess O, Brock M. Neurosurgical procedures in Jehovah's Witnesses: an increased risk? Neurosurgery, 2001; 49(2):266-72; discussion 272-3.
Zhu YJ, Ying GY, Chen AQ, Wang LL, Yu DF, Zhu LL, et al.: Minimally invasive removal of lumbar intradural extramedullary lesions using the interlaminar approach. Neurosurg Focus 2015, 39(2): E10
JH. Waters, AD. Donnenberg. Blood salvage and cancer surgery: should we do it. Transfusion. 2009, 49: 2016-2018.
C.S. Degoute. Controlled hypotension: A guide to drug choice. Drug 67(7)(2007) 1053-1076.
